DescriptionInhibition of estradiol binding by selected estrogens, antiestrogens, and estrogen esters to human aortic tissue in vitro.png
English: Percent inhibition of 1 nM [3H]estradiol binding by co-incubation with 100 nM of different competitor ligands for 1 hour at 37°C (human body temperature) in cultured human aortic smooth muscle cells (SMCs) in vitro. The competitor ligands included the estrogens estradiol (E2), estrone (E1), estriol (E3), 17α-estradiol (17α-E2; alfatradiol); the antiestrogen fulvestrant (Fulv; ICI-182,780); and the estrogen esters estradiol valerate (EV), estradiol cypionate (EC), estradiol benzoate (EB), and estrone sulfate (E1S). The cells were found to express both ERα and ERβ. The shown results relate to estrogen receptor binding affinity (with 50% inhibition of binding corresponding to the half-maximal inhibitory concentration or IC50).
Source of the values:
(April 2000). "Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity". Arterioscler. Thromb. Vasc. Biol.20 (4): 964–72. DOI:10.1161/01.atv.20.4.964. PMID10764660.
to share – to copy, distribute and transmit the work
to remix – to adapt the work
Under the following conditions:
attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.